TRACON PHARMACEUTICALS INC's ticker is TCON and the CUSIP is 89237H209. A total of 34 filers reported holding TRACON PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $189 | -57.7% | 100 | -66.7% | 0.00% | – |
Q4 2022 | $447 | -55.3% | 300 | 0.0% | 0.00% | – |
Q3 2022 | $1,000 | 0.0% | 300 | 0.0% | 0.00% | – |
Q2 2022 | $1,000 | 0.0% | 300 | 0.0% | 0.00% | – |
Q1 2022 | $1,000 | 0.0% | 300 | 0.0% | 0.00% | – |
Q4 2021 | $1,000 | 0.0% | 300 | +50.0% | 0.00% | – |
Q3 2021 | $1,000 | 0.0% | 200 | 0.0% | 0.00% | – |
Q2 2021 | $1,000 | -66.7% | 200 | -50.0% | 0.00% | -100.0% |
Q1 2021 | $3,000 | -50.0% | 400 | -20.0% | 0.00% | -66.7% |
Q4 2020 | $6,000 | +100.0% | 500 | 0.0% | 0.00% | +200.0% |
Q3 2020 | $3,000 | – | 500 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Opaleye Management Inc. | 4,125,322 | $8,251,000 | 3.72% |
Ikarian Capital, LLC | 2,788,853 | $5,577,000 | 1.02% |
Telemetry Investments, L.L.C. | 100,000 | $200,000 | 0.24% |
ACT CAPITAL MANAGEMENT, LLC | 28,500 | $57,000 | 0.08% |
JOHNSON & JOHNSON | 84,003 | $168,000 | 0.04% |
NEA Management Company, LLC | 346,719 | $693,000 | 0.04% |
X-Square Capital, LLC | 17,973 | $36,000 | 0.02% |
BOOTHBAY FUND MANAGEMENT, LLC | 268,301 | $537,000 | 0.01% |
LINDEN ADVISORS LP | 454,916 | $910,000 | 0.01% |
DOWLING & YAHNKE LLC | 47,455 | $95,000 | 0.00% |